RenovoRx Inc
RNXT
NASDAQ
Biotechnology
$1.40
USD
+0.14 (+11.11%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $56.77M
Volume 1.0M
Price Target
$14.00 – $14.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $14.00 and a min estimate of $14.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$14.00
+$5.8 vs prior
Implied Upside
+900.0%
+410.7% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Edward Woo | Ascendiant Capital | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
BOLD
Boundless Bio Inc
$2.83
▲ +2.0%
PMVP
PMV Pharmaceuticals Inc
$1.26
▲ +3.7%
XLO
Xilio Therapeutics Inc
$9.17
▲ +1.8%
DWTX
Dogwood Therapeutics Inc
$2.15
▲ +8.6%
INMB
INmune Bio Inc
$2.17
▲ +4.3%
ATYR
aTyr Pharma Inc
$0.5600
▲ +1.1%
HRTX
Heron Therapeutics Inc
$0.3400
▲ +0.7%
TENX
Tenax Therapeutics Inc
$1.80
▼ -1.6%
XBIT
XBiotech Inc
$2.30
▼ -1.3%
INKT
Mink Therapeutics Inc
$11.27
▲ +2.5%
MNOV
MediciNova Inc
$1.31
▲ 0.0%